OraSure Technologies Inc (OSUR)
5.305
-0.24
(-4.24%)
USD |
NASDAQ |
May 08, 16:00
5.00
-0.30
(-5.75%)
After-Hours: 20:00
OraSure Technologies Enterprise Value: 118.42M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 07, 2024 | 118.42M |
May 06, 2024 | 115.47M |
May 03, 2024 | 114.73M |
May 02, 2024 | 114.00M |
May 01, 2024 | 102.93M |
April 30, 2024 | 99.98M |
April 29, 2024 | 108.09M |
April 26, 2024 | 102.19M |
April 25, 2024 | 97.76M |
April 24, 2024 | 115.47M |
April 23, 2024 | 117.69M |
April 22, 2024 | 104.40M |
April 19, 2024 | 99.24M |
April 18, 2024 | 97.02M |
April 17, 2024 | 97.02M |
April 16, 2024 | 94.81M |
April 15, 2024 | 108.83M |
April 12, 2024 | 116.95M |
April 11, 2024 | 135.40M |
April 10, 2024 | 136.87M |
April 09, 2024 | 147.21M |
April 08, 2024 | 146.47M |
April 05, 2024 | 149.42M |
April 04, 2024 | 153.11M |
April 03, 2024 | 165.65M |
Date | Value |
---|---|
April 02, 2024 | 153.11M |
April 01, 2024 | 158.27M |
March 28, 2024 | 163.44M |
March 27, 2024 | 162.70M |
March 26, 2024 | 158.27M |
March 25, 2024 | 168.61M |
March 22, 2024 | 175.99M |
March 21, 2024 | 177.46M |
March 20, 2024 | 190.74M |
March 19, 2024 | 206.24M |
March 18, 2024 | 211.41M |
March 15, 2024 | 200.34M |
March 14, 2024 | 217.31M |
March 13, 2024 | 228.38M |
March 12, 2024 | 230.59M |
March 11, 2024 | 219.53M |
March 08, 2024 | 243.14M |
March 07, 2024 | 247.57M |
March 06, 2024 | 223.95M |
March 05, 2024 | 226.17M |
March 04, 2024 | 218.05M |
March 01, 2024 | 246.09M |
February 29, 2024 | 240.56M |
February 28, 2024 | 280.04M |
February 27, 2024 | 228.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
84.86M
Minimum
Jun 13 2022
1.145B
Maximum
Aug 05 2020
402.09M
Average
356.49M
Median
Enterprise Value Benchmarks
Integra Lifesciences Holdings Corp | 1.313B |
Insulet Corp | 13.60B |
Perspective Therapeutics Inc | 1.072B |
Xtant Medical Holdings Inc | 122.38M |
Asensus Surgical Inc | 46.93M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 20.07M |
Revenue (Quarterly) | 75.88M |
Total Expenses (Quarterly) | 68.66M |
EPS Diluted (Quarterly) | 0.27 |
Gross Profit Margin (Quarterly) | 46.29% |
Profit Margin (Quarterly) | 26.45% |
Earnings Yield | 13.57% |
Operating Earnings Yield | 11.04% |
Normalized Earnings Yield | 15.93 |